Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications

Overview

Journal Materials (Basel)

Publisher MDPI

Date 2019 Feb 23

PMID 30791358

Citations 139

Authors

Joanna Dulinska-Litewka

Agnieszka Lazarczyk

Przemyslaw Halubiec

Oskar Szafranski

Karolina Karnas

Anna Karewicz

Affiliations

Soon will be listed here.

Abstract

The recent, fast development of nanotechnology is reflected in the medical sciences. Superparamagnetic Iron Oxide Nanoparticles (SPIONs) are an excellent example. Thanks to their superparamagnetic properties, SPIONs have found application in Magnetic Resonance Imaging (MRI) and magnetic hyperthermia. Unlike bulk iron, SPIONs do not have remnant magnetization in the absence of the external magnetic field; therefore, a precise remote control over their action is possible. This makes them also useful as a component of the advanced drug delivery systems. Due to their easy synthesis, biocompatibility, multifunctionality, and possibility of further surface modification with various chemical agents, SPIONs could support many fields of medicine. SPIONs have also some disadvantages, such as their high uptake by macrophages. Nevertheless, based on the ongoing studies, they seem to be very promising in oncological therapy (especially in the brain, breast, prostate, and pancreatic tumors). The main goal of our paper is, therefore, to present the basic properties of SPIONs, to discuss their current role in medicine, and to review their applications in order to inspire future developments of new, improved SPION systems.

Citing Articles

Research status of biomaterials based on physical signals for bone injury repair.

Sun Q, Li C, Liu Q, Zhang Y, Hu B, Feng Q Regen Ther. 2025; 28:544-557.

PMID: 40027992 PMC: 11872413. DOI: 10.1016/j.reth.2025.01.025.

Functionalization of magnetic nanoparticles with 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid as an efficient adsorbent for the Gefitinib removal from water.

Hajiaghababaei L, Mazloomifar A, Khalilian F, Farahani G Sci Rep. 2025; 15(1):5905.

PMID: 39966562 PMC: 11836423. DOI: 10.1038/s41598-025-89641-6.

Hyaluronic Acid-Coated SPIONs with Attached Folic Acid as Potential T2 MRI Contrasts for Anticancer Therapies.

Kasprzyk M, Opila G, Hinz A, Stankiewicz S, Bzowska M, Wolski K ACS Appl Mater Interfaces. 2025; 17(6):9059-9073.

PMID: 39880388 PMC: 11826879. DOI: 10.1021/acsami.4c20101.

Advanced photoluminescent nanomaterials for targeted bioimaging of cancer cells.

Mohammadi T, Gheybalizadeh H, Rahimpour E, Soleymani J, Shafiei-Irannejad V Heliyon. 2025; 11(1):e41566.

PMID: 39850435 PMC: 11754178. DOI: 10.1016/j.heliyon.2024.e41566.

Macrophages co-loaded with drug-associated and superparamagnetic nanoparticles for triggered drug release by alternating magnetic fields.

Desai O, Kumar S, Koster M, Ullah S, Sarker S, Hagemann V Drug Deliv Transl Res. 2025; .

PMID: 39804440 DOI: 10.1007/s13346-024-01774-9.

References

Chang S, Reuter V, Heston W, Bander N, Grauer L, Gaudin P . Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res. 1999; 59(13):3192-8. View

Anzai Y, Piccoli C, Outwater E, Stanford W, Bluemke D, Nurenberg P . Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology. 2003; 228(3):777-88. DOI: 10.1148/radiol.2283020872. View

Ordonez N . Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol. 2003; 27(11):1418-28. DOI: 10.1097/00000478-200311000-00003. View

Restani P, Ballabio C, Cattaneo A, Isoardi P, Terracciano L, Fiocchi A . Characterization of bovine serum albumin epitopes and their role in allergic reactions. Allergy. 2004; 59 Suppl 78:21-4. DOI: 10.1111/j.1398-9995.2004.00568.x. View

Gleich B, Weizenecker J . Tomographic imaging using the nonlinear response of magnetic particles. Nature. 2005; 435(7046):1214-7. DOI: 10.1038/nature03808. View

Holliger P, Hudson P . Engineered antibody fragments and the rise of single domains. Nat Biotechnol. 2005; 23(9):1126-36. DOI: 10.1038/nbt1142. View

Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B . Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol. 2006; 81(1):53-60. DOI: 10.1007/s11060-006-9195-0. View

Maynard A, Aitken R, Butz T, Colvin V, Donaldson K, Oberdorster G . Safe handling of nanotechnology. Nature. 2006; 444(7117):267-9. DOI: 10.1038/444267a. View

Bravo-Osuna I, Ponchel G, Vauthier C . Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles. Eur J Pharm Sci. 2006; 30(2):143-54. DOI: 10.1016/j.ejps.2006.10.007. View

10.

Sayes C, Reed K, Warheit D . Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 2007; 97(1):163-80. DOI: 10.1093/toxsci/kfm018. View

11.

Lee H, Yu M, Park S, Moon S, Min J, Jeong Y . Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. J Am Chem Soc. 2007; 129(42):12739-45. DOI: 10.1021/ja072210i. View

12.

Borlongan C, Masuda T, Walker T, Maki M, Hara K, Yasuhara T . Nanotechnology as an adjunct tool for transplanting engineered cells and tissues. Curr Mol Med. 2007; 7(7):609-18. DOI: 10.2174/156652407782564381. View

13.

Petri-Fink A, Hofmann H . Superparamagnetic iron oxide nanoparticles (SPIONs): from synthesis to in vivo studies--a summary of the synthesis, characterization, in vitro, and in vivo investigations of SPIONs with particular focus on surface and colloidal properties. IEEE Trans Nanobioscience. 2008; 6(4):289-97. DOI: 10.1109/tnb.2007.908987. View

14.

Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S . Stem cell therapy in stroke. Cell Mol Life Sci. 2008; 66(5):757-72. PMC: 11131442. DOI: 10.1007/s00018-008-8346-1. View

15.

Lee C, Jeong H, Kim S, Kim E, Kim D, Lim S . SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes. Int J Pharm. 2009; 371(1-2):163-9. DOI: 10.1016/j.ijpharm.2008.12.021. View

16.

Kell A, Stewart G, Ryan S, Peytavi R, Boissinot M, Huletsky A . Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria. ACS Nano. 2009; 2(9):1777-88. DOI: 10.1021/nn700183g. View

17.

Butoescu N, Jordan O, Burdet P, Stadelmann P, Petri-Fink A, Hofmann H . Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in vitro and in vivo drug release. Eur J Pharm Biopharm. 2009; 72(3):529-38. DOI: 10.1016/j.ejpb.2009.03.003. View

18.

Huang D, Hsiao J, Chen Y, Chien L, Yao M, Chen Y . The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials. 2009; 30(22):3645-51. DOI: 10.1016/j.biomaterials.2009.03.032. View

19.

Mahmoudi M, Simchi A, Imani M, Milani A, Stroeve P . An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure. Nanotechnology. 2009; 20(22):225104. DOI: 10.1088/0957-4484/20/22/225104. View

20.

Hillaireau H, Couvreur P . Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci. 2009; 66(17):2873-96. PMC: 11115599. DOI: 10.1007/s00018-009-0053-z. View